GKB Ophthalmics Ltd. announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. The standalone results indicate a loss of ₹73.94 lakh before tax. The company also disclosed details on legal proceedings, the closure of a subsidiary, and a change in the ownership structure of another subsidiary.
Financial Highlights for Q1 FY27
GKB Ophthalmics Ltd. has released its unaudited financial results for the first quarter of the fiscal year 2027, which concluded on June 30, 2026. The company reported standalone revenue from operations of ₹639.89 lakh. However, the standalone results show a loss of ₹73.94 lakh before exceptional items and tax, and a loss of ₹50.20 lakh for the period after tax, on a standalone basis.
Key Operational Updates
The Board of Directors noted significant developments during the quarter. The company is challenging a recovery proceeding initiated by the Labour Commissioner and Mamlatdar, with a writ petition filed and scheduled for hearing on August 19, 2026. Furthermore, GKB Ophthalmics Products FZE, a wholly-owned subsidiary, completed the closure of its subsidiary, Prime Ophthalmics Products PTY Limited, on July 02, 2026. The investment in this subsidiary amounting to AED 1,69,325.58 was written off.
Subsidiary Restructuring
Additionally, the Board acknowledged the completion of a change in ownership and legal structure for Prescription Optical Products LLC (“POPL”), a subsidiary of GKB Ophthalmics Products FZE. POPL has been updated to a Single Owner LLC. The company clarified that the closure of Prime Ophthalmics Products PTY Limited was not a material subsidiary and its closure will not materially affect the Group’s overall revenue, business, or profitability.
Consolidated Performance
On a consolidated basis, GKB Ophthalmics Ltd. reported revenue from operations of ₹3,303.97 lakh for the quarter. The consolidated results indicate a profit before tax of ₹204.40 lakh, with a profit after tax of ₹184.65 lakh for the period. Total comprehensive income for the period on a consolidated basis was ₹107.27 lakh.
Auditor’s Review
Independent Auditor’s Review Reports on both the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, have been prepared by MSKA & Associates LLP. The auditors stated that based on their review, nothing has come to their attention that causes them to believe that the accompanying statements, prepared in accordance with accounting principles, are not disclosed correctly or contain material misstatements.
Source: BSE
